LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Silverback Therapeutics

Similar companies to Silverback Therapeutics

Silverback Therapeutics Tech Stack

Silverback Therapeutics uses 8 technology products and services including Cloudflare CDN, Drupal, MySQL, and more. Explore Silverback Therapeutics's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Drupal
    Content Management System
  • MySQL
    Database
  • Oracle
    Enterprise
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Google Tag Manager
    Tag Management

Media & News

Silverback Therapeutics's Email Address Formats

Silverback Therapeutics uses at least 1 format(s):
Silverback Therapeutics Email FormatsExamplePercentage
FLast@silverbacktx.comJDoe@silverbacktx.com
48%
Last@silverbacktx.comDoe@silverbacktx.com
3%
First.Last@silverbacktx.comJohn.Doe@silverbacktx.com
1%
FLast@silverbacktx.comJDoe@silverbacktx.com
48%

Frequently Asked Questions

Where is Silverback Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Silverback Therapeutics's main headquarters is located at 500 Fairvew Ave N Suite 600 Seattle, WA 98109 US. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Silverback Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Silverback Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Silverback Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Silverback Therapeutics is a publicly traded company; the company's stock symbol is SPRY.

What is Silverback Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Silverback Therapeutics's official website is silverbacktx.com and has social profiles on LinkedIn.

How much revenue does Silverback Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, Silverback Therapeutics's annual revenue reached $15M.

What is Silverback Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Silverback Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Silverback Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Silverback Therapeutics has approximately 51 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Vice President Human Resources: K. C.Vice President, Development Sciences: G. J.Sr. Director Of Accounting & Controller: D. G.. Explore Silverback Therapeutics's employee directory with LeadIQ.

What industry does Silverback Therapeutics belong to?

Minus sign iconPlus sign icon
Silverback Therapeutics operates in the Biotechnology Research industry.

What technology does Silverback Therapeutics use?

Minus sign iconPlus sign icon
Silverback Therapeutics's tech stack includes Cloudflare CDNDrupalMySQLOracleGoogle CloudjQueryOWL CarouselGoogle Tag Manager.

What is Silverback Therapeutics's email format?

Minus sign iconPlus sign icon
Silverback Therapeutics's email format typically follows the pattern of . Find more Silverback Therapeutics email formats with LeadIQ.

How much funding has Silverback Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Silverback Therapeutics has raised $85M in funding. The last funding round occurred on Sep 23, 2020 for $85M.

When was Silverback Therapeutics founded?

Minus sign iconPlus sign icon
Silverback Therapeutics was founded in 2016.
Silverback Therapeutics

Silverback Therapeutics

Biotechnology ResearchWashington, United States51-200 Employees

We are a clinical-stage biopharmaceutical company leveraging our proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Our platform enables us to strategically pair linker-payloads that modulate key disease-modifying pathways with monoclonal antibodies directed to specific disease sites. Initially, we are creating a new class of targeted immuno-oncology agents that direct a myeloid cell activator to the tumor microenvironment in solid tumors to promote cancer cell killing.

Section iconCompany Overview

Headquarters
500 Fairvew Ave N Suite 600 Seattle, WA 98109 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SPRY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $85M

    Silverback Therapeutics has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Sep 23, 2020 in the amount of $85M.

  • $10M$50M

    Silverback Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $85M

    Silverback Therapeutics has raised a total of $85M of funding over 5 rounds. Their latest funding round was raised on Sep 23, 2020 in the amount of $85M.

  • $10M$50M

    Silverback Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.